ROG - Chinese Cancer Diagnostics Firm Genetron Starts U.S. IPO Effort
Quick Take
Genetron Holdings (GTH) has filed to raise gross proceeds of $100 million from a U.S. IPO, according to an F-1 registration statement.
The firm provides precision oncology diagnosis, monitoring and research services in China.
GTH has grown but that growth is decelerating and the firm is producing increasing operating losses and burning through cash.
Company & Technology
Beijing, China-based Genetron was founded in 2014 to develop precision oncology diagnosis, monitoring and research services in China, covering the full cycle of cancer care, according to Frost & Sullivan.
Management is headed